240 related articles for article (PubMed ID: 22577086)
1. Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices.
Gaujac A; Navickiene S; Collins MI; Brandt SD; de Andrade JB
Drug Test Anal; 2012; 4(7-8):636-48. PubMed ID: 22577086
[TBL] [Abstract][Full Text] [Related]
2. Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies.
Santos MC; Navickiene S; Gaujac A
J AOAC Int; 2017 May; 100(3):820-824. PubMed ID: 28105971
[TBL] [Abstract][Full Text] [Related]
3. Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry.
Gaujac A; Dempster N; Navickiene S; Brandt SD; de Andrade JB
Talanta; 2013 Mar; 106():394-8. PubMed ID: 23598143
[TBL] [Abstract][Full Text] [Related]
4. Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage.
Gambelunghe C; Aroni K; Rossi R; Moretti L; Bacci M
Biomed Chromatogr; 2008 Oct; 22(10):1056-9. PubMed ID: 18506697
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
McKenna DJ; Towers GH; Abbott F
J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
[TBL] [Abstract][Full Text] [Related]
6. Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context.
Lanaro R; Mello SM; da Cunha KF; Silveira G; Corrêa-Neto NF; Hyslop S; Cabrices OG; Costa JL; Linardi A
Drug Test Anal; 2021 Mar; 13(3):664-678. PubMed ID: 33119972
[TBL] [Abstract][Full Text] [Related]
7. Investigation of Ayahuasca β-Carboline Alkaloids and Tryptamine in Sweat Samples from Religious Community Participants by GC-MS.
Tavares L; Monedeiro F; Bordin DM; De Martinis BS
J Anal Toxicol; 2020 Jul; 44(6):601-609. PubMed ID: 32103256
[TBL] [Abstract][Full Text] [Related]
8. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage.
Pires AP; De Oliveira CD; Moura S; Dörr FA; Silva WA; Yonamine M
Phytochem Anal; 2009; 20(2):149-53. PubMed ID: 19140116
[TBL] [Abstract][Full Text] [Related]
9. Ayahuasca and the process of regulation in Brazil and internationally: implications and challenges.
Labate BC; Feeney K
Int J Drug Policy; 2012 Mar; 23(2):154-61. PubMed ID: 21856141
[TBL] [Abstract][Full Text] [Related]
10. Ayahuasca, Personality and Acute Psychological Effects in Neo-Shamanic and Religious Settings in Uruguay.
Apud I; Scuro J; Rodríguez L; Hernandez G; Carrera I; Lozano F; Retta JI
J Psychoactive Drugs; 2023; 55(5):581-591. PubMed ID: 37750012
[TBL] [Abstract][Full Text] [Related]
11. Forbidden therapies: Santo Daime, ayahuasca, and the prohibition of entheogens in Western society.
Blainey MG
J Relig Health; 2015 Feb; 54(1):287-302. PubMed ID: 24477460
[TBL] [Abstract][Full Text] [Related]
12. Determination of dimethyltryptamine and β-carbolines (ayahuasca alkaloids) in plasma samples by LC-MS/MS.
Oliveira CD; Okai GG; da Costa JL; de Almeida RM; Oliveira-Silva D; Yonamine M
Bioanalysis; 2012 Jul; 4(14):1731-8. PubMed ID: 22877219
[TBL] [Abstract][Full Text] [Related]
13. Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?
Lanaro R; Calemi DB; Togni LR; Costa JL; Yonamine M; Cazenave Sde O; Linardi A
J Psychoactive Drugs; 2015; 47(2):132-9. PubMed ID: 25950593
[TBL] [Abstract][Full Text] [Related]
14. Altered states of consciousness and short-term psychological after-effects induced by the first time ritual use of ayahuasca in an urban context in Brazil.
Barbosa PC; Giglio JS; Dalgalarrondo P
J Psychoactive Drugs; 2005 Jun; 37(2):193-201. PubMed ID: 16149333
[TBL] [Abstract][Full Text] [Related]
15. Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members.
Santos RG; Landeira-Fernandez J; Strassman RJ; Motta V; Cruz AP
J Ethnopharmacol; 2007 Jul; 112(3):507-13. PubMed ID: 17532158
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Cytotoxicity of Ayahuasca Beverages.
Simão AY; Gonçalves J; Gradillas A; García A; Restolho J; Fernández N; Rodilla JM; Barroso M; Duarte AP; Cristóvão AC; Gallardo E
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260723
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
[TBL] [Abstract][Full Text] [Related]
18. The globalization of ayahuasca: harm reduction or benefit maximization?
Tupper KW
Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
[TBL] [Abstract][Full Text] [Related]
19. Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.
McKenna DJ
Pharmacol Ther; 2004 May; 102(2):111-29. PubMed ID: 15163593
[TBL] [Abstract][Full Text] [Related]
20. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]